Titel

Merkliste
1 Ergebnisse

Image_1_Serum Levels of Soluble Urokinase Plasminogen Activ..:

Sven H. Loosen (5866946) ; Joao Gorgulho (10508612) ; Markus S. Jördens (5906504)...
https://figshare.com/articles/figure/Image_1_Serum_Levels_of_Soluble_Urokinase_Plasminogen_Activator_Receptor_Predict_Tumor_Response_and_Outcome_to_Immune_Checkpoint_Inhibitor_Therapy_tiff/14350661. , 2021

Link: https://doi.org/10.3389/fonc.2021.646883.s001

RT Journal
T1 <Title>Image_1_Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy.tiff</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_14350661&Exemplar=1&LAN=DE
				
A1 Sven H. Loosen (5866946)
A1 Joao Gorgulho (10508612)
A1 Markus S. Jördens (5906504)
A1 Maximilian Schulze-Hagen (10508615)
A1 Fabian Beier (4823637)
A1 Mihael Vucur (180119)
A1 Anne T. Schneider (9406427)
A1 Christiane Koppe (9406430)
A1 Alexander Mertens (686999)
A1 Jakob N. Kather (6240275)
A1 Frank Tacke (170575)
A1 Verena Keitel (219301)
A1 Tim H. Brümmendorf (9263733)
A1 Christoph Roderburg (180091)
A1 Tom Luedde (180139)
YR 2021
K1 Cancer
K1 Cancer Cell Biology
K1 Cancer Diagnosis
K1 Cancer Genetics
K1 Cancer Therapy (excl. Chemotherapy and Radiation Therapy)
K1 Chemotherapy
K1 Haematological Tumours
K1 Molecular Targets
K1 Radiation Therapy
K1 Solid Tumours
K1 Oncology and Carcinogenesis not elsewhere classified
K1 immunotherapy
K1 checkpoint inhibitors
K1 prognosis
K1 biomarker
K1 nivolumab
K1 pembrolizumab
K1 IRAE
JF https://figshare.com/articles/figure/Image_1_Serum_Levels_of_Soluble_Urokinase_Plasminogen_Activator_Receptor_Predict_Tumor_Response_and_Outcome_to_Immune_Checkpoint_Inhibitor_Therapy_tiff/14350661
LK http://dx.doi.org/https://doi.org/10.3389/fonc.2021.646883.s001
DO https://doi.org/10.3389/fonc.2021.646883.s001
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)